(Q35941603)

11 August 2017

1 reference

title

Tumor-host immune interactions and dendritic cell dysfunction (English)

1 reference

11 August 2017

1 reference

Li Yang

1

1 reference

11 August 2017

David P Carbone

series ordinal

2

1 reference

11 August 2017

language of work or name

1 reference

1 January 2004

1 reference

Advances in Cancer Research

11 August 2017

published in

1 reference

11 August 2017

volume

92

1 reference

11 August 2017

page(s)

13-27

1 reference

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Tumor-induced immune dysfunctions caused by myeloid suppressor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Cross-presentation: a general mechanism for CTL immunity and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

The immunophenotype of minimally differentiated acute myeloid leukemia (AML-M0): reduced immunogenicity and high frequency of CD34+/CD38- leukemic progenitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

MCA Sarcomas Induced in scid Mice are More Immunogenic than MCA Sarcomas Induced in Congenic, Immunocompetent Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

NKT cells: facts, functions and fallacies.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Altered immune responses in interleukin 10 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Intraperitoneal macrophages and tumor immunity: A review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Host-tumor interactions during the regression of a rat histiocytoma, AK-5.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

The Th1-Th2 classification of cellular immune responses: concepts, current thinking and applications in haematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Comparison of the effects of immunosuppressive factors from newly established colon carcinoma cell cultures on human lymphocyte proliferation and cytokine secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Induction of protective anti-tumor immunity by gene-modified dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Immunology of the peritoneal cavity: relevance for host-tumor relation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Synergy between tumor immunotherapy and antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

CD4+ CD25+ suppressor T cells: more questions than answers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Differential tumor surveillance by natural killer (NK) and NKT cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Decreased tumor surveillance in perforin-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

The role of natural killer cells in immune surveillance of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2804%2992002-7

7 January 2021

10.1016/S0065-230X(04)92002-7

Identifiers

DOI

0 references

1 reference